Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Wave Quantum Inc. (NYSE: QBTS) ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services, ...

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life ...

Nathan Mammen and Cole Tipton of Snell & Wilmer LLP address the question as to how AI could affect or even upend determining ...

One way to sustain a leading position is by achieving data dominance, leveraging artificial intelligence (AI ... and scientific discovery. To achieve this future, the industry must prioritize ...